SCHEMBL6976960

SCHEMBL6976960

CC(C)(C)c1nc(C(=O)O)nc(C(C)(C)C)c1O

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GLRA3 O75311 1/20 0.38
GLRB P48167 1/20 0.38
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30723220 0.82
SCHEMBL9431575 0.74 GLRA3 (0.32) GLRA3GLRB
SCHEMBL9120689 0.71 PTGS1 (0.35) PTGS1PTGS2
SCHEMBL1146219 0.68 TSHR (0.38)
Hydrochloric Acid SCHEMBL2032392 0.65 TSHR (0.36)
Potassium SCHEMBL30932480 0.65 TSHR (0.36)
SCHEMBL29223372 0.65 TSHR (0.36)
Oteracil SCHEMBL7697987 0.64 ALOX15 (0.32)
SCHEMBL10110991 0.62 ALDH1A1 (0.37)
SCHEMBL25136496 0.61 ALDH1A1 (0.42) GLRA3GLRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5356898-A Antiinflammatory agents, antiallergens, antiulcer agents WARNER-LAMBERT COMPANY (US) 1994-10-18 US claimed
EP-0569493-A4 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES 1993-11-24 EP claimed
EP-0569493-A1 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES WARNER-LAMBERT COMPANY (US) 1993-11-18 EP claimed
WO-1992013844-A1 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES WARNER-LAMBERT COMPANY (US) 1992-08-20 WO claimed
EP-0652874-B1 2-HETEROCYCLIC-5-HYDROXY-1,3-PYRIMIDINES USEFUL AS ANTIINFLAMMATORY AGENTS WARNER LAMBERT CO (US) 2003-11-05 EP disclosed
US-5432181-A Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1995-07-11 US disclosed
EP-0652874-A1 2-HETEROCYCLIC-5-HYDROXY-1,3-PYRIMIDINES USEFUL AS ANTIINFLAMMATORY AGENTS WARNER-LAMBERT COMPANY (US) 1995-05-17 EP disclosed
US-5356898-A Antiinflammatory agents, antiallergens, antiulcer agents WARNER-LAMBERT COMPANY (US) 1994-10-18 US disclosed
US-5340815-A Inhibitors of 5-lipoxygenase and/or cyclooxygenase WARNER-LAMBERT COMPANY (US) 1994-08-23 US disclosed
US-5312821-A Antiulcer agents WARNER-LAMBERT COMPANY (US) 1994-05-17 US disclosed
WO-1994003448-A1 2-HETEROCYCLIC-5-HYDROXY-1,3-PYRIMIDINES USEFUL AS ANTIINFLAMMATORY AGENTS WARNER-LAMBERT COMPANY (US) 1994-02-17 WO disclosed
EP-0569493-A4 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES 1993-11-24 EP disclosed
EP-0569491-A1 2-SUBSTITUTED-4,6-DI-TERTIARY-BUTYL-5-HYDROXY-1,3-PYRIMIDINES USEFUL AS ANTIINFLAMMATORY AGENTS WARNER-LAMBERT COMPANY (US) 1993-11-18 EP disclosed
EP-0569493-A1 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES WARNER-LAMBERT COMPANY (US) 1993-11-18 EP disclosed
US-5240929-A Lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1993-08-31 US disclosed
US-5187175-A 2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1993-02-16 US disclosed
WO-1992013844-A1 SUBSTITUTED 4,6-DI-TERTIARY-BUTYL-5-HYDROXY-PYRIMIDINES WARNER-LAMBERT COMPANY (US) 1992-08-20 WO disclosed
WO-1992013536-A1 2-SUBSTITUTED-4,6-DI-TERTIARY-BUTYL-5-HYDROXY-1,3-PYRIMIDINES USEFUL AS ANTIINFLAMMATORY AGENTS WARNER-LAMBERT COMPANY (US) 1992-08-20 WO disclosed